1. Home
  2. FOXX vs CNSY Comparison

FOXX vs CNSY Comparison

Compare FOXX & CNSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

N/A

Current Price

$2.51

Market Cap

17.3M

Sector

N/A

ML Signal

N/A

Logo Cerenome Inc. Common Stock

CNSY

Cerenome Inc. Common Stock

N/A

Current Price

$1.56

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOXX
CNSY
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
20.6M
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
FOXX
CNSY
Price
$2.51
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $27.75
AVG Volume (30 Days)
4.8K
★ 162.8K
Earning Date
09-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.61
EPS
N/A
★ N/A
Revenue
★ $52,584,432.00
$5,213,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$414.61
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.71
$1.64
52 Week High
$7.90
$4.03

Technical Indicators

Market Signals
Indicator
FOXX
CNSY
Relative Strength Index (RSI) 47.16 20.90
Support Level $2.39 N/A
Resistance Level $2.69 $3.28
Average True Range (ATR) 0.17 0.18
MACD 0.01 0.00
Stochastic Oscillator 67.31 8.18

Price Performance

Historical Comparison
FOXX
CNSY

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About CNSY Cerenome Inc. Common Stock

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Share on Social Networks: